Reuters sources reported that Morgan Stanley is handling a deal involving a group of banks providing about 700 million euros ($954 million) of debt financing to back a sale of German medical patch manufacturer LTS Lohmann.

Reuters said that LTS, in which Novartis, with worldwide locations — including six U.S. divisions — owns a 43 percent stake, was put up for sale in July and is expected to garner more than 1 billion euros.

To read the entire article, click here.